Lack of sustained hemodynamic effects of the beta2-adrenoceptor agonist dopexamine in end-stage congestive heart failure

Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

Michael R. Bristow, Robert Ginsburg, Victor A. Umans et al. · Circulation Research · 1986 · 1.3K citations · Full text

Medicine, Cardiology, Physiology +17

Augmentation of the Plasma Nor-Epinephrine Response to Exercise in Patients with Congestive Heart Failure

Charles A. Chidsey, Donald C. Harrison, Eugene Braunwald · New England Journal of Medicine · 1962 · 441 citations

Life Sciences, Cardiology, Physiology +17

Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.

Michael R. Bristow, Ray E. Hershberger, J. David Port et al. · Molecular Pharmacology · 1989 · 383 citations

Medicine, Cardiology, Pharmacology +13

Dopexamine: a novel agonist at peripheral dopamine receptors and β₂‐adrenoceptors

R.A. Brown, J. Michael Dixon, J B Farmer et al. · British Journal of Pharmacology · 1985 · 202 citations · Full text

Medicine, Pharmacology, Experimental Pharmacology +13

Reduced Effects of Dopexamine on Force of Contraction in the Failing Human Heart Despite Preserved β2-Adrenoceptor Subpopulation

Michael Böhm, Burkert Pieske, Petra Schnabel et al. · Journal of Cardiovascular Pharmacology · 1989 · 42 citations

Medicine, Cardiology, Pharmacology +16